Patent details
EP3274333 Title: CABOZANTINIB SALTS AND THEIR USE AS ANTI-CANCER AGENTS
Basic Information
- Publication number:
- EP3274333
- PCT Application Number:
- EP2016056262
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP167118181
- PCT Publication Number:
- WO2016150963
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CABOZANTINIB SALTS AND THEIR USE AS ANTI-CANCER AGENTS
- French Title of Invention:
- SELS DE CABOZANTINIBE ET LEUR APPLICATION EN TANT QU'AGENTS ANTI-CANCÉREUX
- German Title of Invention:
- CABOZANTINIBSALZE UND IHRE VERWENDUNG ALS ANTIKREBSMITTEL
- SPC Number:
Dates
- Filing date:
- 22/03/2016
- Grant date:
- 24/04/2019
- EP Publication Date:
- 31/01/2018
- PCT Publication Date:
- 29/09/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/04/2019
- EP B1 Publication Date:
- 24/04/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 22/03/2020
- Expiration date:
- 22/03/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/04/2019
- Name:
- Sandoz AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- STEFINOVIC, Marijan
- Address:
- Austria (AT)
2
- Name:
- SCHREINER, Erwin, Paul
- Address:
- Austria (AT)
Priority
- Priority Number:
- 15160877
- Priority Date:
- 25/03/2015
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/47; A61P 35/00; C07D 215/22;
Publication
European Patent Bulletin
- Issue number:
- 201917
- Publication date:
- 24/04/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|